Literature DB >> 2172520

Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea.

H Hakoda1, Y Ito.   

Abstract

1. Comparative studies on the effects of vasoactive intestinal polypeptide (VIP), commercially available VIP antiserum or VIP antagonists [Ac-Tyr1, D-Phe2]-GRF(1-29)-NH2 and [4-Cl-D-Phe6, Leu17]-VIP on excitatory neuroeffector transmission in the dog and cat trachea were performed with microelectrode, double sucrose-gap, and tension recording methods. 2. VIP (10(-11)-10(-9) M) had no effect on the resting membrane potential or on the input resistance of the smooth muscle cells of dog and cat trachea. However, with increased concentrations (greater than 10(-8) M) VIP hyperpolarized the membrane and decreased the input resistance of the membrane in both tissues. 3. VIP (10(-10)-10(-7) M) dose-dependently reduced the amplitude of the contractions evoked through the nervous structure excited by field stimulation in the combined presence of indomethacin (10(-5) M) and guanethidine (10(-6) M) in the dog, and in the presence of guanethidine (10(-6) M) in cat trachea. In parallel with actions on twitch contractions, VIP (10(-11)-10(-7) M) reduced the amplitude of the excitatory junction potentials (EJPs) evoked through the nervous structure excited by single pulse field stimulation in both tissues. 4. VIP (10(-9) M) had no effect on the post-junctional response of smooth muscle cells to exogenous acetylcholine (ACh) (10(-9)-10(-5) M). 5. During repetitive field stimulation at the stimulus frequency of 0.033-0.1 Hz, the amplitude of the EJPs was gradually reduced, and VIP (10(-9) M) enhanced this depression phenomenon in the dog and cat trachea. 6. EJPs also showed summation when repetitive field stimulation was applied at high frequency (20 Hz) in the dog trachea. The slope of the relationship between the relative amplitude of the EJP and number of stimuli at 20 Hz was 2.2 +/- 0.4 mV/stimulation (n = 4) in the dog trachea. However, in the cat trachea, summation of EJPs was not prominent, giving a mean slope of 0.6 +/- 0.2 mV/stimulation (n = 6) measured by the microelectrode method. VIP (10(-9) M) shifted downward the relationship between the relative amplitude of the EJP and the number of stimuli at 20 Hz in both tissues. 7. Overnight incubation with VIP antiserum (10(-6) g/ml) had little effect on the depression of the EJP in the dog and cat trachea, or the summation of the EJP observed in the dog trachea.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172520      PMCID: PMC1181639          DOI: 10.1113/jphysiol.1990.sp018204

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro.

Authors:  J Epelbaum; L Tapia-Arancibia; J Besson; W H Rotsztejn; C Kordon
Journal:  Eur J Pharmacol       Date:  1979-10-15       Impact factor: 4.432

2.  Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways.

Authors:  Y Matsuzaki; Y Hamasaki; S I Said
Journal:  Science       Date:  1980-12-12       Impact factor: 47.728

3.  Evidence for nonadrenergic inhibitory nerves in the guinea pig trachealis muscle.

Authors:  R F Coburn; T Tomita
Journal:  Am J Physiol       Date:  1973-05

4.  Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects.

Authors:  R D Dey; W A Shannon; S I Said
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

5.  A nonadrenergic vagal inhibitory pathway to feline airways.

Authors:  L Diamond; M O'Donnell
Journal:  Science       Date:  1980-04-11       Impact factor: 47.728

6.  Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide.

Authors:  L S Frawley; J D Neill
Journal:  Neuroendocrinology       Date:  1981-08       Impact factor: 4.914

7.  Noradrenergic inhibitory innervation of canine airways.

Authors:  J A Russell
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-01

8.  Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies.

Authors:  J M Lundberg
Journal:  Acta Physiol Scand Suppl       Date:  1981

9.  Spontaneous activity in the trachea of dogs treated with indomethacin: an experimental model for aspirin-related asthma.

Authors:  Y Ito; K Tajima
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

10.  Effects of peptidases on non-adrenergic, non-cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP- and PHI-induced relaxation.

Authors:  J L Ellis; S G Farmer
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

View more
  9 in total

1.  Effects of vasoactive intestinal polypeptide antagonists on cholinergic neurotransmission in dog and cat trachea.

Authors:  Z Q Xie; T Hirose; H Hakoda; Y Ito
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach.

Authors:  Pascal G Leclere; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Alpha 1-adrenoceptor-activated cation currents in neurones acutely isolated from rat cardiac parasympathetic ganglia.

Authors:  Hitoshi Ishibashi; Mari Umezu; Il-Sung Jang; Yushi Ito; Norio Akaike
Journal:  J Physiol       Date:  2003-02-21       Impact factor: 5.182

4.  Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

Authors:  Y M Qian; R L Jones
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

5.  VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.

Authors:  H Aizawa; H Inoue; M Shigyo; S Takata; H Koto; K Matsumoto; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

6.  Effects of PAF on excitatory neuro-effector transmission in dog airways.

Authors:  K Tashiro; Z Xie; Y Ito
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  The possible role of nitric oxide in relaxations and excitatory neuroeffector transmission in the cat airway.

Authors:  H Tanaka; L Jing; S Takahashi; Y Ito
Journal:  J Physiol       Date:  1996-06-15       Impact factor: 5.182

8.  The role of nitric oxide in cholinergic neurotransmission in rat trachea.

Authors:  K Sekizawa; T Fukushima; Y Ikarashi; Y Maruyama; H Sasaki
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Role of nitric oxide in non-adrenergic, non-cholinergic relaxation and modulation of excitatory neuroeffector transmission in the cat airway.

Authors:  L Jing; R Inoue; K Tashiro; S Takahashi; Y Ito
Journal:  J Physiol       Date:  1995-02-15       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.